Andrew Jacobs
Posts
To Curb Bird Flu, Taxpayers Pay Millions to Kill Poultry. Is It Needed?
Big poultry farms have received millions of dollars for their losses. Animal welfare groups contend that aid reinforces inhumane cullings of sick birds.
A New Film at SXSW Warns of the Potential Harm of Microplastics
At SXSW, a documentary traces the arc of plastics in our lives, and highlights evolving research of the potential harm of its presence in our...
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains...
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains...
Nursing Home Staffing Shortages and Other Problems Still Persist
Infection control lapses, severe staffing shortages and lowering vaccination rates have continued to plague many facilities beyond the pandemic.
FDA Issues Warning Over Misuse of Ketamine Therapy
Unsupervised treatment — fueled by telemedicine prescriptions — for various psychiatric problems poses a number of health risks, the agency said.
Soy, Oat and Almond Drinks Can be Called Milk: FDA
Plant-based beverage makers hailed the agency’s decision but objected to the recommendation for labels to specify the nutritional differences with cow’s milk.
FDA Seeks More Authority to Oversee CBD Products
The agency wants Congress to intervene, saying it does not have adequate oversight powers to ensure the safety of the myriad cannabidiol products derived from...
Legal Use of Hallucinogenic Mushrooms Begins in Oregon
On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is...
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.